NCT07198230
- Conditions
- Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
Clinical trial condition
Relapsed and Refractory
Explore clinical trials studying Relapsed and Refractory. Study availability and eligibility vary by location and protocol.
4 public trials
3 recruiting studies
Relapsed and Refractory trial results
NCT06651853
- Conditions
- Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
Recruiting
A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies
NCT04283006
- Conditions
- Disease Attributes, Lymphoid Hematological Malignancies, Pathologic Processes, +3 more
- Locations
-
- The First Hospital of Zhejiang Medical Colleage Zhejiang University Hangzhou, Zhejiang, China
NCT03376958
- Conditions
- Diffuse Large B Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Oncology Department of The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China